| 英文别名 |
Odanacatib;(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide;Odanacatib (MK-0822);(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide;MK0822;MK-0822;UNII-N673F6W2VH;MK 0822;Odanacatib (MK 0822);N673F6W2VH;(S)-N-(1-CYANOCYCLOPROPYL)-4-FLUORO-4-METHYL-2-((S)-2,2,2-TRIFLUORO-1-(4'-(METHYLSULFONYL)BIPHENYL-4-YL)ETHYLAMINO)PENTANAMIDE;(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl];Odanacatib [USAN];DTXSID40209075;(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide;BDBM50255753;NSC-766811;MK-0822;MK 0822;MK0822;C25H27F4N3O3S;N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide;AKOS015900719;AS-19562;ODANACATIB [JAN];AC-27468;ODANACATIB [MART.];ODANACATIB [MI];BCP9001020;DB06670;Odanacatib [USAN:INN];NS00072488;N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methyl sulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide;SW219669-1;ODANACATIB [INN];NCGC00346637-01;EX-A552;MFCD11042419;MK-0822A;D08955;CS-0277;L-1037536;J-690332;603139-19-1;N-(1-Cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide;Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)-, (2S)-;cas:603139-19-1;Odanacatib;NSC766811;ODANACATIB [WHO-DD];Odanacatib (JAN/USAN);SCHEMBL1496266;CHEMBL481611;MLS006010197;CCG-269888;HY-10042;GTPL6478;Q2014070;s1115;SMR004676504;(S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethyl)amino)pentanamide;Odanacatib (MK0822);BCPP000141 |
微信公众号
客服
